Old Mission Capital LLC Bristol Myers Squibb CO Transaction History

Old Mission Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$72.62 - $79.98 $212,558 - $234,101	-2,927 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $179,951 - $215,778	2,927 New	2,927 $214,000
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $229,883 - $258,550	-3,874 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $222,483 - $246,541	3,874 New	3,874 $234,000
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $298,522 - $336,710	-5,409 Closed	0 $0

Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $273,316 - $340,658	5,409 New	5,409 $299,000

2,554

1.49B

25.9M

20M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $88.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Old Mission Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Old Mission Capital LLC with notifications on news.